Related Experiment Video

Updated: Jul 14, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia

H J Avis1, M N Vissers, E A Stein

  • 1Academic Medical Centre, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Arteriosclerosis, Thrombosis, and Vascular Biology
|June 16, 2007
PubMed

Insights

Statin therapy effectively lowers cholesterol in children with heterozygous familial hypercholesterolemia (HeFH). This meta-analysis found statins to be safe and well-tolerated in this age group, supporting early treatment consideration.

Area of Science:

  • Pediatric Cardiology
  • Lipid Metabolism
  • Pharmacology

Background:

  • Children with heterozygous familial hypercholesterolemia (HeFH) exhibit arterial wall changes early in life.
  • Premature atherosclerotic cardiovascular disease is a significant risk in untreated HeFH patients.

Purpose of the Study:

  • To evaluate the efficacy of statin therapy in children with HeFH.
  • To assess the safety profile of statin treatment in pediatric HeFH patients.

Main Methods:

  • Meta-analysis of randomized, double-blind, placebo-controlled trials.
  • Included 6 studies with 798 children aged 8–18 years with HeFH.
  • Treatment duration ranged from 12 to 104 weeks.

Main Results:

  • Statins significantly reduced total cholesterol, LDL cholesterol, and apolipoprotein B.
  • Statins significantly increased HDL cholesterol and apolipoprotein A1.
  • No significant differences in adverse events, sexual development, muscle, or liver toxicity were observed between statin and placebo groups. Minimal growth difference favored statin use.

Conclusions:

  • Statin treatment is efficacious in reducing lipid levels in children with HeFH.
  • Statin therapy demonstrates a favorable safety profile in children aged 8–18 with HeFH.
  • Consideration of statin treatment for children with HeFH is supported, pending further long-term safety data.
Abstract

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...